ADXS

Advaxis, Inc. News Headlines

$2.94
*  
0.02
0.68%
Get ADXS Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading ADXS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Sector Update: Healthcare Shares Mixed Pre-Market; Aratana Files for Product License For Cancer Immunotherapy
7/2/2014 8:39:13 AM - MT Newswires

Sector Update: Healthcare
7/2/2014 8:38:15 AM - MT Newswires

Aratana Reports Filing For Product License For AT-014 In U.S. - Quick Facts
7/2/2014 7:52:00 AM - RTT News

Eagle Pharmaceuticals (EGRX) in Focus: Stock Moves 5.6% Higher - Tale of the Tape
7/1/2014 9:21:00 AM - Zacks.com

Advaxis To Evaluate ADXS-HPV In Phase 1/2 Study - Quick Facts
6/16/2014 9:02:00 AM - RTT News

Sector Update: Healthcare Shares Mixed Pre-Market; Isis Earns Milestone Payment
6/10/2014 8:40:33 AM - MT Newswires

Sector Update: Healthcare
6/10/2014 8:39:56 AM - MT Newswires

Sector Update: Healthcare Shares Mixed Pre-Market
6/6/2014 8:45:22 AM - MT Newswires

Sector Update: Healthcare
6/6/2014 8:44:47 AM - MT Newswires

Advaxis Mirrors Imclone Systems Prior To Acquisition
6/2/2014 5:17:00 PM - Seeking Alpha

Advaxis: ADXS-cHER2 Gets Orphan Drug Designation - Quick Facts
5/27/2014 7:39:00 AM - RTT News

Advaxis Announces Orphan Drug Status For ADXS-HPV In Cervical Cancer
5/1/2014 8:06:00 AM - RTT News

Advaxis's ADXS-HPV Phase 2 Results In Context
2/16/2014 10:10:00 AM - Seeking Alpha

San Fran Biotech Week Aftermath: Advaxis Is Primed To Take Off
2/6/2014 11:59:00 AM - Seeking Alpha

Inovio IL-33 Results Provide Further Validation Of Platform
2/3/2014 11:19:00 AM - Seeking Alpha

Two Deals In Two Months: Great Achievement For Advaxis
1/30/2014 1:01:00 PM - Seeking Alpha

Advaxis And Inovio Race For First Cervical Cancer Immunotherapy
1/23/2014 9:05:00 AM - Seeking Alpha

Covidien Completes Confluent Surgical Sale - Analyst Blog
1/21/2014 5:00:01 PM - Zacks.com

Wright Medical Rises on OrthoRecon Sale - Analyst Blog
1/17/2014 3:50:01 PM - Zacks.com

Generic Unit at Perrigo Looks Promising - Analyst Blog
1/17/2014 12:30:01 PM - Zacks.com

ZELTIQ (ZLTQ) Worth Watching: Stock Soars 19.9% - Tale of the Tape
1/17/2014 10:25:01 AM - Zacks.com

Agios Pharmaceuticals (AGIO) Surges: Stock Moves 18.6% Higher - Tale of the Tape
1/16/2014 10:21:01 AM - Zacks.com

St. Jude Announces Promising Guidance - Analyst Blog
1/15/2014 4:00:01 PM - Zacks.com

BAX Recalls Parenteral Nutrition Injections - Analyst Blog
1/6/2014 8:15:01 PM - Zacks.com

Neogen Acquires Insecticide Maker - Analyst Blog
1/3/2014 4:10:01 PM - Zacks.com